Ibuprofen (IBU) is one of the most widely consumed non-steroidal anti-inflammatory drugs (NSAIDs) worldwide, and its improper disposal has raised significant concern for the World Health Organization. In recent years, several technologies have been developed as alternatives for managing pharmaceutical-derived organic micropollutants (OMPs). This study investigates the biodegradation and biotransformation of IBU mediated by whole-cells of fungi isolated from iron mine soils in the Amazon region. The strains Trichoderma pseudoasperelloides CBMAI 2752 and Penicillium sp. cf. guaibinense CBMAI 2758 were selected for biodegradation experiments using a three-variable Box-Behnken factorial design. Both strains achieved over 99 % IBU biodegradation under multiple conditions, with pH emerging as a key parameter influencing efficiency. The positive Pareto chart values (6.74 and 4.65) indicated that lower pH values enhanced the biodegradation process. Three potential metabolites were identified by LC–MS, including 2-(2-hydroxy-4-isobutylphenyl)propanoic acid. Toxicity assays with zebrafish embryos revealed that extracts obtained after IBU biodegradation and biotransformation were non-toxic at the tested concentrations, allowing normal embryonic development. In contrast, commercial IBU was classified as toxic, with no embryo formation observed. Overall, this research highlights the remarkable biotechnological potential of Amazonian soil fungi for the efficient degradation of IBU, offering an ecologically sustainable solution to mitigate pharmaceutical contamination in global aquatic environments.
扫码关注我们
求助内容:
应助结果提醒方式:
